Lifecore Inc. to acquire Lifecore Biomedical, Inc.

Lifecore Inc. has agreed to acquire Lifecore Biomedical, Inc. in a transaction designed to take the healthcare company private. The deal was announced on 28 September 2026. Both the acquirer and the target are based in the United States. The consideration for the acquisition consists of cash and an earn-out component. No specific headline offer value was reported in the available data. The transaction is currently at the firm intention stage, with no completion date yet established. This move will remove Lifecore Biomedical from public markets, allowing the combined entity to operate without the immediate pressures of public reporting. The structure of the deal, involving both immediate cash and future performance-based payments, suggests a phased integration approach. However, no further details on the specific terms of the earn-out or the total potential value have been disclosed. The parties have indicated a clear intent to proceed, though the finalisation of the deal remains pending. Regulatory approvals and other standard closing conditions are expected to be required before the transaction can be fully executed. The healthcare sector continues to see significant consolidation activity, with private equity and strategic buyers seeking to streamline operations and focus on long-term growth. This particular deal represents a significant shift for Lifecore Biomedical, marking the end of its public listing era.